Gilead Science Inc. (GILD) is extending Tuesday’s high volume gain with another 2.9% of upside. This impressive move has driven the stock to fresh June highs as a major bottom begins to take shape. Gilead is leaving behind a very solid base and, like much of the Biotech sector, is setting up well for more upside.
